Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45

Oncogene

Volumn 18, Issue 18, 1999, Pages 2892-2900

  Zhan, Qimin ^a,b   Antinore, Michael J ^a   Wang, Xin Wei ^a   Carrier, France ^a,c   Smith, Martin L ^a,d   Harris, Curtis C ^a   Fornace Jr , Albert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cdc2; Cyclin B1; G2 checkpoint; Gadd45; UV radiation

Indexed keywords

ALKYLATING AGENT; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; CYCLIN B1; CYCLIN E; HEAT SHOCK PROTEIN; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MITOSIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION;

ANTIBODIES, MONOCLONAL; CARCINOMA; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; COLONIC NEOPLASMS; CYCLIN B; CYCLIN E; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENES, MYC; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROTEINS; RECOMBINANT PROTEINS; RNA, ANTISENSE; STAUROSPORINE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0033529121     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202667     Document Type: Article

References (34)

1. Agarwal ML, Agarwal A, Taylor WR and Stark GR. (1995). Proc. Natl. Acad. Sci. USA, 92, 8493-8497.
2. Bernhard EJ, Maity A, Muschel RJ and McKenna WG. (1995). Radiat. Environ. Biophys., 34, 79-83.
3. Carrier F, Smith ML, Bae I, Kilpatrick KE, Chen CY, Johnson KJ, Henner WD, Gilmer T, Kastan MB and Fornace Jr AJ. (1994). J. Biol. Chem., 269, 32672-32677.
4. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. (1995). Science, 267, 1353-1356.
5. Dulic V, Stein GH, Far DF and Reed SI. (1998). Mol. Cell. Biol., 18, 546-557.
6. Elledge SJ. (1996). Science, 274, 1664-1672.
7. Fan S, Smith ML, Rivet II DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ and O'Connor PM. (1995). Cancer Res., 55, 1649-1654.
8. Fujii-Nakata T, Ishimi Y, Okuda A and Kikuchi A. (1992). J. Biol. Chem., 267, 20980-20986.
9. Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF. (1996). Science, 271, 1744-1747.
10. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B and Liebermann DA. (1995). Oncogene, 10, 2263-2270.
11. Hartwell LH and Kastan MB. (1994). Science, 266, 1821-1828.
12. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler K and Vogelstein B. (1997). Molecular Cell, 1, 3-11.
13. Kao GD, McKenna WG, Maity A, Blank K and Muschel RJ. (1997). Cancer Res., 57, 753-758.
14. Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA. (1995). Oncogene, 11, 1675-1683.
15. Khan SH and Wahl GM. (1998). Cancer Res., 58, 396-401.
16. Kilpatrick KE, Carrier F, Smith ML, Chen CY, Lee AJ, Rusnak DW, Kastan MB, Fornace AJJ, Champion BR, Gilmer TM, et al. (1995). Hybridoma, 14, 355-359.
17. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
18. Lanni JS and Jacks T. (1998). Mol. Cell. Biol., 18, 1055-1064.
19. Maity A, McKenna WG and Muschel RJ. (1995). EMBO J., 14, 603-609.
20. Medema RH, Klompmaker R, Smits VA and Rijksen G. (1998). Oncogene, 16, 431-441.
21. O'Connor PM. (1997). Cancer Surv. 29, 151-182.
22. Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo IJ, Barrett SF, Hickson ID and Fornace Jr AJ. (1991). Mol. Cell. Biol., 11, 1009-1016.
23. Paulovich AG, Toczyski DP and Hartwell LH. (1997). Cell, 88, 315-321.
24. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W and Friend S. (1995). Cancer Res., 55, 1643-1648.
25. Rupp RA, Snider L and Weintraub H. (1994). Genes Dev., 8, 1311-1323.
26. Smith ML, Chen I, Zhan Q. Bae I, Chen C, Gilmer T, Kastan MB, O'Connor PM and Fornace Jr AJ. (1994). Science, 266, 1376-1380.
27. Smith ML and Fornace Jr AJ. (1996). Mutation Res., 340, 109-124.
28. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM and Fornace Jr AJ. (1996). Oncogene, 13, 2255-2263.
29. Stewart N, Hicks GG, Paraskevas F and Mowat M. (1995). Oncogene, 10, 109-115.
30. Thompson DA, Belinsky G, Chang THT, Jones DL, Schlegel R and Munger K. (1997). Oncogene, 15, 3025-3035.
31. Turner DL and Weintraub H. (1994). Genes Dev., 8, 1434-1447.
32. Wang XW, Zhan Q, Coursen JD, Khan M, Kontny HU, O'Connor PM, Fornace Jr AJ and Harris CC. (1997). Proc. Am. Assoc. Cancer Res., 38, 201.
33. Zhan Q, Lord KA, Alamo IJ, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA and Fornace Jr, AJ. (1994). Mol. Cell. Biol., 14, 2361-2371.
34. Zhan Q, El-Deiry W, Bae I, Alamo Jr I, Kastan MB, Vogelstein B and Fornace Jr AJ. (1995). Int. J. Oncology, 6, 937-946.